Considerations for rare variants in drug metabolism genes and the clinical implications

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2014-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/17425255.2014.903239PMID 24673405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Searching for missing heritability: Designing rare variant association studies

  2014cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

  2014cited by this paper
• Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.

  2013influential reference
• New approaches to molecular diagnosis.

  2013cited by this paper
• Complexities of CYP2D6 gene analysis and interpretation

  2013cited by this paper
• In search of low-frequency and rare variants affecting complex traits

  2013cited by this paper
• Analysis of 6,515 exomes reveals a recent origin of most human protein-coding variants

  2013cited by this paper
• BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge

  2013cited by this paper
• HLA Typing from 1000 Genomes Whole Genome and Whole Exome Illumina Data

  2013cited by this paper
• Candidate gene association studies: a comprehensive guide to useful in silico tools

  2013cited by this paper
• Ethical and legal implications of whole genome and whole exome sequencing in African populations

  2013cited by this paper
• Characterization of the genetic variation present in CYP3A4 in three South African populations

  2013cited by this paper
• Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes

  2013influential reference
• Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

  2013cited by this paper
• Emerging patterns of somatic mutations in cancer

  2013cited by this paper
• Evaluating empirical bounds on complex disease genetic architecture

  2013cited by this paper
• Whole-Exome Sequencing Reveals a Rapid Change in the Frequency of Rare Functional Variants in a Founding Population of Humans

  2013cited by this paper
• Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure

  2013cited by this paper
• Challenges in the Pharmacogenomic Annotation of Whole Genomes

  2013cited by this paper
• 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples

  2013cited by this paper
• Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.

  2013cited by this paper
• Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

  2013cited by this paper
• Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment

  2013influential reference
• Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

  2013cited by this paper
• Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.

  2013cited by this paper
• Insights from genome-wide association studies of drug response.

  2013cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database

  2013cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

  2013cited by this paper
• Genetic variations of human CYP2D6 in the Chinese Han population.

  2013influential reference
• Pharmacogenomics discovery and implementation in genome‐wide association studies era

  2013cited by this paper
• Implications of the incidentalome for clinical pharmacogenomics.

  2013cited by this paper
• Genetic polymorphisms of drug metabolizing enzymes and transporters: the long way from bench to bedside.

  2012cited by this paper
• Epigenomics and Interindividual Differences in Drug Response

  2012cited by this paper
• Personalized medicine: is it a pharmacogenetic mirage?

  2012cited by this paper
• Analysis of 6,515 exomes reveals a recent origin of most human protein-coding variants

  2012cited by this paper
• Novel Rare Variants in Congenital Cardiac Arrhythmia Genes are Frequent in Drug-induced Torsades de Pointes

  2012cited by this paper
• Future prospects for pharmacogenetics in the quest for personalized medicine.

  2012cited by this paper
• Pharmacogenomics of adverse drug reactions: implementing personalized medicine.

  2012cited by this paper
• An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People

  2012cited by this paper
• Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes

  2012influential reference
• Relating human genetic variation to variation in drug responses.

  2012cited by this paper
• A Clinician‐Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record

  2012cited by this paper
• The AmpliChip™ CYP450 Genotyping Test

  2012cited by this paper
• Annotation of functional variation in personal genomes using RegulomeDB

  2012cited by this paper
• An integrated map of genetic variation from 1,092 human genomes

  2012cited by this paper
• Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications.

  2011influential reference
• A User's Guide to the Encyclopedia of DNA Elements (ENCODE)

  2011cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

  2011influential reference
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cited by this paper
• Genomics really gets personal: How exome and whole genome sequencing challenge the ethical framework of human genetics research

  2011cited by this paper
• A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian population.

  2011cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy

  2011cited by this paper
• Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation

  2011cited by this paper
• The functional spectrum of low-frequency coding variation

  2011cited by this paper
• Bioinformatics challenges for personalized medicine

  2011cited by this paper
• Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.

  2011influential reference
• CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

  2011cited by this paper
• Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data

  2011cited by this paper
• Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants

  2010cited by this paper
• Genome-wide association studies in pharmacogenomics

  2010cited by this paper
• Characterization of the genetic profile of CYP2C19 in two South African populations.

  2010cited by this paper
• Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9

  2010cited by this paper
• Race, ethnicity, ancestry, and pharmacogenetics.

  2010cited by this paper
• Phenotype prediction of nonsynonymous single nucleotide polymorphisms in human phase II drug/xenobiotic metabolizing enzymes: perspectives on molecular evolution

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Clinical assessment incorporating a personal genome.

  2010cited by this paper
• Pharmacogenomics: a systems approach

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• Deep resequencing reveals excess rare recent variants consistent with explosive population growth

  2010cited by this paper
• Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population

  2010influential reference
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects

  2009influential reference
• Clinical pharmacogenetics and potential application in personalized medicine.

  2008cited by this paper
• The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

  2008cited by this paper
• Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals

  2007cited by this paper
• Distribution and intensity of constraint in mammalian genomic sequence.

  2005cited by this paper
• Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

  2005influential reference
• A novel intronic mutation, 2988G>A, with high predictivity for impaired dunction of cytochrome P450 2D6 in white subjects

  2004influential reference
• Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

  2003cited by this paper
• Unique CYP2D6 activity distribution and genotype‐phenotype discordance in black Americans

  2002cited by this paper
• Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.

  1999cited by this paper
• The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

  1994cited by this paper
• Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.

  1990cited by this paper
• Identification of the primary gene defect at the cytochrome P450 CYP2D locus

  1990cited by this paper

• New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity.

  2025cites this paper
• Pharmacogenomics revolutionizing cardiovascular therapeutics: A narrative review

  2024cites this paper
• Pharmacogenomic diversity in psychiatry: Challenges and Opportunities in Africa

  2024cites this paper
• Design and performance of a long-read sequencing panel for pharmacogenomics

  2022cites this paper
• Targeted Genotyping in Clinical Pharmacogenomics: What is Missing?

  2022cites this paper
• UKnowledge UKnowledge

  2022cites this paper
• Precision Medicine Using Pharmacogenomic Panel-Testing: Current Status and Future Perspectives.

  2022cites this paper
• Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability

  2021cites this paper
• Translating Pharmacogenomic Research to Therapeutic Potentials (Bench to Bedside)

  2021cites this paper
• Precision Medicine Using Pharmacogenomic Panel-Testing

  2020cites this paper
• Technologies for Pharmacogenomics: A Review

  2020cites this paper
• Pharmacogenes (PGx-genes): Current understanding and future directions.

  2019cites this paper
• Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity

  2019cites this paper
• Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

  2019cites this paper
• Beyond drugs: the evolution of genes involved in human response to medications

  2019influential citation
• Studying how genetic variants affect mechanism in biological systems.

  2018cites this paper
• Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.

  2018cites this paper
• Personalised Medicine: The Odyssey from Hope to Practice

  2018cites this paper
• Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait

  2017cites this paper
• What is the role of CYP genotyping in psychiatry?

  2017cites this paper
• The global spectrum of protein-coding pharmacogenomic diversity

  2016cites this paper
• CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women

  2016cites this paper
• Toward a Global Roadmap for Precision Medicine in Psychiatry: Challenges and Opportunities

  2016cites this paper
• Investigating the functional significance of genome-wide variants associated with antipsychotic treatment response in schizophrenia

  2015cites this paper
• Clinical applications of CYP genotyping in psychiatry

  2014influential citation
• Pharmacogenomics of acetaminophen in pediatric populations: a moving target

  2014cites this paper